Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2634]

Minimally invasive procedure effectively treats small kidney cancers

Minimally invasive procedure effectively treats small kidney cancers

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer-free longer

ASCO GU 2026: Belzutifan plus pembrolizumab post-surgery helps ccRCC patients at high risk for relapse stay cancer...

ASCO GU 2026: Combo targeting blood vessel growth controls ccRCC better than single agent

ASCO GU 2026: Combo targeting blood vessel growth controls ccRCC better than single agent

ASCO GU 2026: Blood test predicts which bladder cancer patients may safely skip surgery

ASCO GU 2026: Blood test predicts which bladder cancer patients may safely skip surgery

ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery

ASCO GU 2026: Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery

ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

ASCO GU 2026: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic...

ASCO GU 2026: Enfortumab vedotin pembrolizumab combo may reduce risk of recurrence for some MIBC cases

ASCO GU 2026: Enfortumab vedotin pembrolizumab combo may reduce risk of recurrence for some MIBC cases

New study suggests a “kick it while it’s down” approach to cancer treatment could improve cure rates

New study suggests a “kick it while it’s down” approach to cancer treatment could improve cure rates

Study identifies long-term health risks among testicular cancer survivors treated with contemporary chemotherapy regimens

Study identifies long-term health risks among testicular cancer survivors treated with contemporary chemotherapy...

Study shows advanced PET/CT imaging can help improve long-term outcomes for men with recurrent prostate cancer

Study shows advanced PET/CT imaging can help improve long-term outcomes for men with recurrent prostate cancer

More from ecancer